Advertorial

ERT Announces the Appointment of Joel Morganroth, MD as Interim CEO

Posted: 21 December 2010 | | No comments yet

ERT, today confirmed that the effective date of the previously announced retirement of Dr. Michael J. McKelvey, its President and CEO, is December 21, 2010…

ERT, today confirmed that the effective date of the previously announced retirement of Dr. Michael J. McKelvey, its President and CEO, is December 21, 2010...

ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, today confirmed that the effective date of the previously announced retirement of Dr. Michael J. McKelvey, its President and CEO, is December 21, 2010.

Joel Morganroth

ERT Announces the Appointment of Joel Morganroth, MD as Interim CEO

Dr. Joel Morganroth, currently ERT’s Chairman and Chief Scientific Officer, has also been elected by the Board as President and CEO until ERT hires a permanent CEO. Dr. Morganroth has served as the Chairman of ERT’s Board of Directors since 1999 and as Chief Scientific Officer since April 2006. He previously served as the company’s Chief Executive Officer from 1993 to March 2001 and also has consulted for ERT since 1977. Dr. Morganroth is also a globally recognized cardiologist and clinical researcher and has had more than 10 years’ experience as a medical review officer/expert for the U.S. Food and Drug Administration (FDA).

Dr. Morganroth commented, “We thank Dr. McKelvey for his years of service and wish him well in his future endeavors.”

“ERT is a leading provider of innovative solutions and is well positioned for continued growth. In my expanded role, I will continue to leverage my experience and knowledge of the organization and domain expertise to strengthen our position in clinical research associated with Cardiac Safety, Respiratory and electronic Patient Reported Outcomes [ePRO]. With our superb management team, we will continue our goal of enhanced growth through the exciting development of adjacent markets.”

For further information on ERT and its technology and services please email [email protected], call +1 215 972 0420 or visit www.ert.com.

Related organisations

Related people